These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 33841389)

  • 21. Heme oxygenase-1 and neopterin plasma/serum levels and their role in diagnosing active and latent TB among HIV/TB co-infected patients: a cross sectional study.
    Uwimaana E; Bagaya BS; Castelnuovo B; Kateete DP; Godwin A; Kiwanuka N; Whalen CC; Joloba ML
    BMC Infect Dis; 2021 Jul; 21(1):711. PubMed ID: 34315412
    [TBL] [Abstract][Full Text] [Related]  

  • 22. QuantiFERON-TB Gold Plus combined with HBHA-Induced IFN-γ release assay improves the accuracy of identifying tuberculosis disease status.
    Tang J; Huang Y; Jiang S; Huang F; Ma T; Qi Y; Ma Y
    Tuberculosis (Edinb); 2020 Sep; 124():101966. PubMed ID: 32866942
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of IFIT3 and ORM1 as Biomarkers for Discriminating Active Tuberculosis from Latent Infection.
    Yang BF; Zhai F; Yu S; An HJ; Cao ZH; Liu YH; Wang R; Cheng XX
    Curr Med Sci; 2022 Dec; 42(6):1201-1212. PubMed ID: 36462134
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reprogramming of Small Noncoding RNA Populations in Peripheral Blood Reveals Host Biomarkers for Latent and Active Mycobacterium tuberculosis Infection.
    de Araujo LS; Ribeiro-Alves M; Leal-Calvo T; Leung J; Durán V; Samir M; Talbot S; Tallam A; Mello FCQ; Geffers R; Saad MHF; Pessler F
    mBio; 2019 Dec; 10(6):. PubMed ID: 31796535
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biomarkers on patient T cells diagnose active tuberculosis and monitor treatment response.
    Adekambi T; Ibegbu CC; Cagle S; Kalokhe AS; Wang YF; Hu Y; Day CL; Ray SM; Rengarajan J
    J Clin Invest; 2015 May; 125(5):1827-38. PubMed ID: 25822019
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The meta-analysis for ideal cytokines to distinguish the latent and active TB infection.
    Wei Z; Li Y; Wei C; Li Y; Xu H; Wu Y; Jia Y; Guo R; Jia J; Qi X; Li Z; Gao X
    BMC Pulm Med; 2020 Sep; 20(1):248. PubMed ID: 32948170
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transcriptomic Biomarkers for Tuberculosis: Validation of
    de Araujo LS; Ribeiro-Alves M; Wipperman MF; Vorkas CK; Pessler F; Saad MHF
    Cells; 2021 Oct; 10(10):. PubMed ID: 34685683
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of the Cepheid 3-gene Host Response Fingerstick Blood Test (MTB-HR) on rapid diagnosis of tuberculosis.
    Wu X; Tan G; Ma J; Yang J; Guo Y; Lu H; Ke H; Li M; Tang YW; Sha W; Yu F
    Emerg Microbes Infect; 2023 Dec; 12(2):2261561. PubMed ID: 37848021
    [No Abstract]   [Full Text] [Related]  

  • 29. Screening of potential biomarkers for distinguishing between latent and active tuberculosis in children using bioinformatics analysis.
    Shao M; Wu F; Zhang J; Dong J; Zhang H; Liu X; Liang S; Wu J; Zhang L; Zhang C; Zhang W
    Medicine (Baltimore); 2021 Feb; 100(5):e23207. PubMed ID: 33592820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential Gene Expression of ASUN, NEMF, PTPRC and DHX29: Candidate Biomarkers for the Diagnosis of Active and Latent Tuberculosis.
    Mamishi S; Pourakbari B; Sadeghi RH; Marjani M; Mahmoudi S
    Infect Disord Drug Targets; 2021; 21(2):268-273. PubMed ID: 32167431
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Application of ImmunoScore Model for the Differentiation between Active Tuberculosis and Latent Tuberculosis Infection as Well as Monitoring Anti-tuberculosis Therapy.
    Zhou Y; Du J; Hou HY; Lu YF; Yu J; Mao LY; Wang F; Sun ZY
    Front Cell Infect Microbiol; 2017; 7():457. PubMed ID: 29164066
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identifcation of differentially expressed long non-coding RNAs in CD4+ T cells response to latent tuberculosis infection.
    Yi Z; Li J; Gao K; Fu Y
    J Infect; 2014 Dec; 69(6):558-68. PubMed ID: 24975173
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene expression profiling identifies candidate biomarkers for new latent tuberculosis infections. A cohort study.
    Herrera M; Keynan Y; McLaren PJ; Isaza JP; Abrenica B; López L; Marin D; Rueda ZV
    PLoS One; 2022; 17(9):e0274257. PubMed ID: 36170228
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel biomarkers distinguishing active tuberculosis from latent infection identified by gene expression profile of peripheral blood mononuclear cells.
    Lu C; Wu J; Wang H; Wang S; Diao N; Wang F; Gao Y; Chen J; Shao L; Weng X; Zhang Y; Zhang W
    PLoS One; 2011; 6(8):e24290. PubMed ID: 21904626
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potential of DosR and Rpf antigens from Mycobacterium tuberculosis to discriminate between latent and active tuberculosis in a tuberculosis endemic population of Medellin Colombia.
    Arroyo L; Marín D; Franken KLMC; Ottenhoff THM; Barrera LF
    BMC Infect Dis; 2018 Jan; 18(1):26. PubMed ID: 29310595
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Association between Circulating microRNAs and the Risk of Active Disease Development from Latent Tuberculosis Infection: a Nested Case-Control Study.
    Xin H; Cao X; Du Y; Yan J; He R; Liu Z; Zhang H; He Y; Zhang B; Wang D; Guan L; Shen F; Feng B; Quan Z; He Y; Liu J; Jin Q; Pan S; Gao L
    Microbiol Spectr; 2022 Jun; 10(3):e0262521. PubMed ID: 35435753
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aberrant expression of long non-coding RNAs in peripheral blood mononuclear cells response to tuberculosis in children.
    Zhong X; Lei S; Lin JW; Ren M; Shu M
    Medicine (Baltimore); 2022 Oct; 101(42):e31065. PubMed ID: 36281118
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of Validity of a Blood-Based 3-Gene Signature Score for Progression and Diagnosis of Tuberculosis, Disease Severity, and Treatment Response.
    Warsinske HC; Rao AM; Moreira FMF; Santos PCP; Liu AB; Scott M; Malherbe ST; Ronacher K; Walzl G; Winter J; Sweeney TE; Croda J; Andrews JR; Khatri P
    JAMA Netw Open; 2018 Oct; 1(6):e183779. PubMed ID: 30646264
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mycobacterium tuberculosis thymidylate kinase antigen assays for designating incipient, high-risk latent M.tb infection.
    Wayengera M; Kateete DP; Asiimwe B; Joloba ML
    BMC Infect Dis; 2018 Mar; 18(1):133. PubMed ID: 29548281
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combination of Blood Routine Examination and T-SPOT.TB Assay for Distinguishing Between Active Tuberculosis and Latent Tuberculosis Infection.
    Luo Y; Tang G; Yuan X; Lin Q; Mao L; Song H; Xue Y; Wu S; Ouyang R; Hou H; Wang F; Sun Z
    Front Cell Infect Microbiol; 2021; 11():575650. PubMed ID: 34277462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.